articleTop 10% cited

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy☆

Gynecologic Oncology · 2003 · Vol. 89(3) · pp. 460–469

Robert Giuntoli(Mayo Clinic in Arizona)Daniel S. Metzinger(University of Louisville)Connie S. DiMarco(Mayo Clinic in Arizona)S. Stephen(Mayo Clinic)Jeff A. Sloan(Mayo Clinic)Gary L. Keeney(WinnMed)Bobbie S. Gostout✉(Mayo Clinic in Arizona)

View via DOI Publisher page

Uterine Myomas and Treatments Endometrial and Cervical Cancer Treatments Sarcoma Diagnosis and TreatmentMedicineAdjuvant therapyStage (stratigraphy)LeiomyosarcomaUterusRetrospective cohort studyMultivariate analysisProportional hazards modelRadiation therapyEndometrial cancer

MeSH terms

AdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansLeiomyosarcomaLymph NodesMiddle AgedNeoplasm StagingOvaryPrognosisRetrospective StudiesUterine NeoplasmsSurvival Rate

Citations

469

FWCI

11.10

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)